3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Recurrence
2
Pancreatic Neoplasms
2
Neoplasms
2
Lymphoma, B-Cell
2
Hematologic Neoplasms
2
Sarcoma
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Metastatic Solid Tumors
1
Mesothelioma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Hemorrhage
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Gynecological Solid Tumors
1
Fallopian Tube Neoplasms
1
Diarrhea
1
Colitis
1
Childhood Solid Tumor
1
Interventions
Loperamide
4
Irinotecan
4
Probiotics
3
Fecal Microbiota Transplantation
3
Octreotide
2
Leucovorin
2
Fluorouracil
2
Calcium Aluminosilicate
2
telotristat ethyl
1
shosaiko-to
1
maltodextrin
1
ceterizine hydrochloride
1
capivasertib
1
cabazitaxel
1
bile acid binding proteins
1
XRP6258
1
Theophylline
1
Temozolomide
1
Surveys and Questionnaires
1
Sulfasalazine
1
Sugars
1
Standard of Care
1
Raloxifene Hydrochloride
1
Radiation
1
Prednisone
1
Oxaliplatin
1
Long-Term Synaptic Depression
1
Injections
1
Granulocyte Colony-Stimulating Factor
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Diarrhea
×
Cell- and Tissue-Based Therapy
×
Clear all
NCT02814864
2021-08-03
PRISME
Assistance Publique - Hôpitaux de Paris
Phase 2
Unknown
12 enrolled